Stay updated on Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.

Latest updates to the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter revision updated from v3.6.3 to v3.6.4. This appears to be a minor metadata/page revision rather than a substantive change to study content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This represents a minor site update or patch rather than changes to the study content.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page's revision tag was updated to v3.6.2, signaling a minor update to the page rather than a modification to the study information.SummaryDifference0.1%

- Check53 days agoChange DetectedEnrollment status updated to no longer looking for participants, indicating recruitment has ended. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added along with an Intervention/Treatment heading and a UI revision to v3.6.0.SummaryDifference0.5%

- Check60 days agoChange DetectedThe page shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a new version of the page was published, reflecting minor edits or metadata updates rather than substantive changes to the study details.SummaryDifference0.1%

- Check81 days agoChange DetectedNew page revision tag added: v3.5.4, indicating a recent update to the study details page. This revision is a backend/content update and does not modify the study data or displayed information.SummaryDifference0.1%

Stay in the know with updates to Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.